Skip to main content
ASPHO Logo
Menu Journal My Account Contact Join/Renew
Login
  • Meetings & Events
    • Conference
      • 2021 Conference
        • Back to Meetings & Events
        • 2021 Conference Overview
        • Schedule of Events
        • PTCTC Schedule
        • Plan Your Experience
        • Registration Rates
        • Register Yourself
        • Register A Colleague
        • Accepted Papers and Posters
        • Cancellation Policy
        • Continuing Education
        • Educational Symposia
        • Sponsors
        • Conference Planning Committee
        • Virtual Support and Advertising
        • FAQs
      • Meetings Archive
      • Press | 2018 Conference
      • 2018 Call for Papers and Posters
        • Back to Meetings
        • 2019 Conference
        • Schedule of Events
        • Registration Rates
        • Conference Planning Committee
        • Conference Hotel and Travel
        • Faculty
        • 2019 Call for Papers and Posters
        • Continuing Education
        • PBMTC
        • Accepted Papers and Posters
        • Corporate Symposia
        • MOC Opportunities
        • App - Thank you for Attending
        • 2019 Attendee List
      • 2019 Call for Workshops
      • 2018 Conference
        • Schedule of Events
        • Accepted Papers and Posters
      • 2016 Annual Meeting
        • Overview
        • Attendee List
        • ASPHO Virtual Bag
        • Corporate Forum Symposia/Education Theaters
        • Accepted Papers and Posters
          • Accepted A-G
          • Accepted H-M
          • Accepted N-Z
          • 2016 Searchable Abstract Database
        • Exhibit Hall
        • Sponsors
        • Annual Meeting Brochure
        • 2017 Call for Workshops
        • Virtual Bag
        • Schedule of Events
        • Continuing Education
        • Attendee List
        • 2017 Searchable Abstract Database
        • Accepted Papers and Posters
        • Corporate Forum Symposia/Education Theater
        • Travel
        • Program Committee
        • Commercial Support
        • Exhibit with ASPHO
        • Commercial Support
          • Commercial Support
            • Commercial Support
            • Commercial Support
            • Industry Relations Council
            • Advertising
            • Exhibiting and Advertising
              • Exhibit and Advertising
              • Commercial Support
    • Summer Symposium
    • Review Course
      • Anderson 2019
      • McClain 2019
      • Adams 2019
      • Moran 2019
      • Effinger 2019
      • 2021 Review Course
      • Schedule
      • Learning Objectives and CME
      • Faculty
      • Planning Committee
      • Review Course Archive
      • Fangusaro 2021
      • Brown 2021
      • Young 2021
      • Harker-Murray 2021
      • Effinger 2021
      • Pai 2021
      • Grace 2021
      • Rogers 2021
      • Anderson 2021
      • Powers 2021
      • McClain 2021
      • Neunert 2021
      • Fleming 2021
      • Mullen 2021
      • Pommert 2021
      • Meade 2021
      • Greengard 2021
      • Fox 2021
      • Bercovitz 2021
      • Brock 2021
      • Adams 2021
      • Loh 2021
      • O'Brien 2021
      • Walterhouse 2021
      • Pulsipher 2021
      • Oberley 2021
      • Rodriguez-Galindo 2021
      • Kesselheim 2021
      • Frei-Jones 2021
      • Allen 2021
      • 2015 Online Review Course CME Certificates
      • 2019 Planning Committee
      • 2019 Schedule
      • 2019 Travel
      • 2019 Review Course Early Career
      • 2019 Review Course Directors
        • 2019 Review Course Faculty
      • Oberley 2019
      • O'Brien 2019
      • Pai 2019
      • Pulsipher 2019
      • Rodriguez-Galindo 2019
      • Rogers 2019
      • Walterhouse 2019
      • Young 2019
      • Park 2019
      • Malec 2019
      • Evaluations
      • Brown 2019
      • Allen 2019
      • Fangusaro 2019
      • Fleming 2019
      • Frei-Jones 2019
      • Grace 2019
      • Harker-Murray 2019
      • Heeney 2019
      • Kesselheim 2019
      • Loh 2019
      • Mascarenhas 2019
      • Neunert 2019
    • Events Calendar
  • Knowledge Center
    • Products
      • KARE Toolkit: Knowledge and Assessment Resources
        • CME for KARE
        • CME for RC On-Demand
        • CME for PHO Review Course On Demand
        • CME for KARE Plus
        • CME for KARE Plus Hematology
        • CME for KARE Plus Oncology
        • The KARE Toolkit - Index of Topics
      • Recordings
      • Webinars
      • ASPHOcast
      • 2020 Compensation Survey
    • Online Review Course
    • Pediatric Blood & Cancer
      • Access Journal
      • Online Access Instructions
    • ASPHO eNews
      • August 2015 Enews
      • June 2015 Enews
      • April 2015 Enews
      • February 2015 Enews
      • December 2014 Enews
      • October 2014 Enews
      • August 2014 Enews
      • June 2014 Enews
      • April 2014 Enews
      • February 2014 Enews
      • December 2013 Enews
      • October 2013 Enews
      • August 2013 Enews
      • June 2013 Enews
      • April 2013 Enews
      • February 2013 Enews
      • October 2014 Enews
      • October 2015 Enews
      • December 2015 Enews
      • February 2016 Enews
      • April 2016 Enews
      • June 2016 Enews
        • DSIG Student Registration
      • August 2016 Enews
      • October 2016 Enews
      • December 2016 Enews
      • February 2017 Enews
      • April 2017 Enews
      • June 2017 Enews
      • August 2017 Enews
      • October 2017 Enews
      • December 2017 Enews
      • February 2018 Enews
      • April 2018 Enews
      • June 2018 Enews
      • August 2018 eNews
      • October 2018 eNews
      • February 2019 eNews
      • Member Insights: eNews 2018 Highlights
      • April 2019 eNews
      • June 2019 eNews
      • August 2019 eNews
      • October 2019 eNews
      • December 2019 eNews
      • April 2021 eNews
    • Pediatric Blood & Cancer - Call for Applications for Deputy Editor
    • October 2015 Enews
    • Advocacy Sample
    • Health Policy & Advocacy
      • 2016 August Advocacy Brief
      • 2016 December Advocacy Brief
      • 2017 February Advocacy Brief
      • 2017 May Advocacy Brief
      • 2017 September Advocacy Brief
      • 2017 November Advocacy Brief
      • 2018 Advocacy Brief - March
      • Contact Your Members of Congress
      • 2018-Advocacy-Brief-June
      • 2018-Advocacy-Brief-September
      • Advocacy Brief December 2018
      • 2019 Advocacy Brief - March
      • March 2019 Advocacy Brief
      • June 2019 Advocacy Brief
      • September 2019 Advocacy Brief
      • March 2020 Advocacy Brief
      • June 2020 Advocacy Brief
      • September 2020 Advocacy Brief
      • December 2020 Advocacy Brief
    • 2017 Workforce Survey Report
    • Help Fund the STAT Act
    • Practice and Quality
      • Choosing Wisely®
      • Endorsements
      • ASPHO Endorsements member only
    • COVID–19 Resources
  • Career Development
    • Mentoring
      • Enroll as a Mentee
      • Enroll as a Mentor
    • Awards
      • Distinguished Career Award
      • Oski Memorial Lectureship
      • International Travel Awards
      • Arceci Innovation Award
      • Buchanan Lectureship
      • Young Investigator Award
      • Young Investigator Form
      • EC Travel Stipend Form
      • Early Career Travel Stipend
      • Advanced Practice Professional Award
      • Clinician Educator Award
      • Clinician Educator Award
      • Northwestern Mutual Award for Excellence in Childhood Cancer Survivorship
    • Career Center
    • Fellowship Resources
      • Post-PHO Fellowship Program Directory
      • Fellowship Program Directors' Resources
    • Certification
      • Continuing Medical Education
      • advocating for moc
      • ABP MOC Letter Nov 2015
      • 2019 ABP Hematology/Oncology Content Outline
    • 2019 ASPHO Award Recipients
    • Workforce
  • Membership
    • Who Belongs
    • Benefits
    • Join Us
    • Renew
    • Membership Application
    • Fellows Group Application
    • Member Community
    • Special Interest Groups
      • Adolescent and Young Adult SIG
      • Advanced Practice Provider SIG
      • Cancer Predisposition SIG
      • Clinical Immunology SIG
      • Diversity SIG
        • 2017 DSIG Travel Award
      • Global Hem Onc SIG
      • Hemoglobinopathy SIG
      • Informatics, Innovation and Entrepreneurship SIG
      • Integrative Pediatric Hematology/Oncology SIG
      • Palliative Care SIG
      • Physician Scientist SIG
      • Quality Improvement and Patient Safety SIG
      • Small Program SIG
      • Vascular Anomalies SIG
      • Clinical Immunology SIG Webinar
      • Well-Being SIG
    • Enriching the Future
      • ETF Donors
      • ETF FAQ
      • ETF Programs
      • ETF Award Recipients
      • Donate
    • Stay Connected with ASPHO
    • New Member
    • Trainee Membership Level
  • About
    • Governance
      • 2017 Election Nominations
      • 2019 Board and Nominating Committee members
    • Strategic Plan
      • Leadership Domain
      • Education Domain
      • Career Domain
      • Administration Domain
    • Committees
      • Early Career Council
    • Policies
      • Advertising Sponsorship
      • Support of CME
      • Committee Policies, Responsibilities, and Resources
      • Conflict of Interest and Disclosure for Volunteers
      • Distinguished Career Award Eligibility Criteria
      • Diversity Statement
      • Investment
      • Member Mailing List
      • Oski Eligibility Criteria
      • Presidential Stipend
      • Records Retention
      • Reserve Fund
      • Reviews and Endorsements
      • Speaker Reimbursement
      • Surveying Members
      • Whistleblower
      • Workshop Session
      • Young Investigator Award
      • Early Career Travel Stipend
      • Buchanan Lectureship Eligibility
    • Terms of Use
    • Contact Us
    • 2016 Election Nominations
    • 2015 Election Candidates
    • FDA Approves Dinutuximab
    • Q&A Amy Billett
    • Fund Raising Policy
    • Support and Advertising
      • Sponsorship
      • Exhibit
      • Advertising
      • Industry Relations Council
    • Diversity & Inclusion
  • 2017 Annual Meeting Session Recordings
  • 2018 Annual Meeting Session Recordings
  • George R. Buchanan Lectureship Award Presentation
  • Cancer Predispositions in Clinical Practice
  • Evidence and Equipoise in Pediatric Thrombosis - Updates from Randomized Controlled Trials
  • Playing on Our Strengths - Developing Interprofessional Teams in Pediatric Hematology-Oncology
  • Providing Optimal Pediatric Palliative Care: Overcoming the Barriers
  • When in Quebec, Do What the Quebecers Do (Part Deux) - It's All About Platelets!
  • Allogeneic Hematopoietic Stem Cell Transplantation (SCT) for Pediatric Patients with ALL in the era of Tyrosine Kinase Inhibitors, Novel Immunotherapies and 'MRD Status'
  • Award Presentations
  • Hemophilic Arthropathy, More Than Meets the Eye: Advances in Early Disease Detection from Clinical Tools to Musculoskeletal Imaging
  • ZFNs, CrispR/Cas9 and TALENS- Oh My!
  • Collaboration in the Treatment of Liver Tumors
  • Leukemia
  • Solid Tumors/Lymphoma
  • Hematology I
  • Beyond Antibodies and CAR T Cells: Challenges and Opportunities in Manipulating the Pediatric Cancer Immunome
  • Blood Clots in Sick Kids: A critical mini-review of venous thrombo-embolism in selected high-risk pediatric populations
  • It's not just about Diversity: Improving the Outcomes for All by Moving toward Equity
  • Children's Oncology Group (COG)
  • Outcomes Research
  • Social Media: The Good, The Bad, and Beyond
  • Sickle Cell Disease in the AYA population: Management Challenges for the Pediatric Hematologist
  • Molecularly Defined Rare Pediatric Sarcomas: An Update for the General Oncologist
  • Mechanisms of Tumor Microenvironment Immune Mediated Resistance and Methods of Therapeutic Circumvention
  • Behind the Scenes at Pediatric Blood & Cancer: Everything You Always Wanted to Know About Getting Published
  • New Insights in Inherited Hematologic Diseases
  • Changing Workforce of Pediatric Hematology/Oncology
  • New Diagnostic and Therapeutic Approaches of Opportunistic (Viral/Fungal) Infections in the Pediatric Cancer Patient
  • New Mutations and Targeted Therapies in Langerhans Cell Histiocytosis
  • Physician, Sustain Thyself: Building Resilience to Prevent Burnout
  • Practicing Precision in Pediatric Oncology: Three Perspectives
  • What's Happening in DC? A Look at ASPHO Advocacy Efforts
  • Critical Care of the Immunocompromised Pediatric Hematology/Oncology Patient
  • Brain Tumors
  • Hematology II
  • Sponsor, Exhibit, and Advertise
    • Sponsorship
    • Exhibits
    • Advertising
    • Industry Relations Council
    • Exhibits Adveritising
    • Commercial Support
  • Ward Testing OSE
  • 2018 Session | George R. Buchanan Lectureship Award Presentation
  • 2018 Session | Plenary Paper Session 2001-2002
  • 2018 Session | St. Baldrick's Foundation Robert J. Arceci Innovation Award Announcement
  • 2018 Session | Plenary Session—Health Care in the Current Political Climate: Stormy Days Ahead?
  • 2018 Session | Pediatric Ependymoma: The Science Driving Patient Care
  • 2018 Session | Iron: Let's Get Pumped
  • 2018 Session | Extracellular Vesicle Trafficking—Biology and Translational Impact in Hematology and Cancer
  • 2018 Session | Relapsed, Refractory, Metastatic Bone Sarcomas: New Insights on Pathogenesis, Prognosis and Treatment
  • 2018 Session | Alpha Thalassemia—A Growing Public Health Disease with Changing Landscape of In-Utero and Post-Natal Therapy
  • 2018 Session | Decision Making in Benign Hematology: Living in a World Without Randomized Trials
  • 2018 Session | Northwestern Mutual Award for Excellence in Childhood Cancer Survivorship
  • 2018 Session | Early Career Travel Stipend Awards
  • 2018 Session | Young Investigator Award Presentations
  • 2018 Session | Management of Extracranial Germ Cell Tumors in Adolescent and Young Adult Population
  • 2018 Session | Challenging Hematologic Complications Post–Stem Cell Transplantation and Beyond
  • 2018 Session | Advanced Symptom Management and End-of-Life Care: Multidisciplinary Primary Palliative Care for Pediatric Hematologists/Oncologists
  • 2018 Session | Paper Session - Solid Tumor
  • 2018 Session | Paper Session - Hematology
  • 2018 Session | Vascular Anomalies: The Great Mimickers
  • 2018 Session | Addressing Sexual Health in Adolescent and Young Adult Patients: What You Should Know as a Pediatric Hematology/Oncology Care Provider
  • 2018 Session | Navigating Intravascular Bottlenecks: A Critical Mini-Review of Pediatric Venous Thromboembolism in the Setting of an Anatomical Thrombophilia
  • 2018 Session | Paper Session - Children's Oncology Group (COG)
  • 2018 Session | Paper Session - Hematology Science
  • 2018 Session | Can Late Effects be Prevented in Pediatric Oncology?
  • 2018 Session | Clash of the Titans: Debates on Best Management of Patients with Bleeding Disorders
  • 2018 Session | Providing Effective Feedback: The Currency of Conflict Resolution
  • 2018 Session | Recent Advances and New Approaches to Rare Hematological Malignancies
  • 2018 Session | Primary and Secondary Stroke Prevention in Sickle Cell Disease: The Debate
  • 2018 Session | Combating an Unmet Need: Psychosocial Health
  • 2018 Session | Renal Tumors Beyond Wilms
  • 2018 Session | Pediatric and Neonatal Transfusion Medicine
  • 2018 Session | Mobile Applications in Clinical Practice
  • 2018 Session | Presidential Symposium—Partnering with Patients and Families to Improve Research and Clinical Decision-making
  • 2018 Session | Review of Rare Pediatric Head and Neck Tumors for the General Oncologist
  • 2018 Session | Emerging Therapies in Hemophilia
  • 2018 Session | How Should You Treat That Bug? A Debate About Antimicrobial Management in Fever and Neutropenia
  • 2018 Session | Paper Session with Luminary Investigator - Leukemia
  • 2018 Session | Paper Session with Luminary Investigator - Hematology
  • 2018 Session | Frank A. Oski Memorial Lectureship Award Presentation
  • December 2018 eNews
  • 2019 Session | Splenectomy - The Great Debate
  • 2019 Session | DICER1: Updates on Biology and Clinical Management
  • 2019 Session | Burnout in Pediatric Hematology/Oncology: Moving from Discussion to Action
  • 2019 Session | Diagnostic and Management Conundrums Surrounding Women with Heavy Menstrual Bleeding and Underlying Bleeding Disorders
  • 2019 Session | All That Glitters is Not Gold – How We Differentiate Primary HLH from Fake News
  • Models for International Pediatric Oncology Outreach
  • 2019 Session | Navigating Genetic Testing in the Pediatric Hematology Setting
  • 2019 Session | Radiation Therapy for Pediatric Cancer Patients: Updates and New Modalities
  • 2019 Session | The Microbiome: What Is It and Why Do We Care?
  • 2019 Session | Brain Attack: Therapeutic Advances in Neonatal and Childhood Stroke
  • 2019 Session | Advances in Pediatric AML
  • 2019 Session | Improving Medication Adherence for Adolescents and Young Adults: Is Technology the Answer?
  • 2019 Session | Metabolism in Pediatric Hematology/Oncology - Presidential Symposium
  • 2019 Session | Too Much of a Good Thing – Myeloproliferation in Children
  • 2019 Session | Multiple Bony Lytic Lesions, but Not Langerhans Cell Histiocytosis (LCH) – Now What?
  • 2019 Session | Savior Siblings: Medical, Ethical, and Psychosocial Considerations in using Preimplantation Genetic Diagnosis (PGD) to Ensure a Matched Sibling Donor for Hematopoietic Stem Cell Transplantation (HSCT)
  • 2019 Session | George R. Buchanan Lectureship Award Presentation
  • 2019 Session | 2019 St. Baldrick’s Foundation Robert J. Arceci Innovation Award Announcement and Past Recipient Presentation
  • 2019 Session | Northwestern Mutual Award for Excellence in Childhood Cancer Survivorship Announcement and Frank A. Oski Memorial Lectureship Award Presentation
  • 2019 Session | New Paradigms for Severe Aplastic Anemia: Genetic Screening, Eltrombopag, and Up Front Unrelated Donor BMT
  • 2019 Session | Not Too Young for That Cancer: Adolescent and Young Adult Carcinomas
  • 2019 Session | Transforming the Treatment of Chronic Pain
  • 2019 Session | Putting an End to End Organ Damage in Sickle Cell Disease
  • 2019 Session | Defining Pediatric MDS: A Morphologic or Molecular Diagnosis?
  • 2019 Session | The Power of One: Present Challenges in Treating Rare Diseases
  • 2019 Session | Hematological Manifestations of Immune Deficiencies and Dysregulatory Disorders: When should you look harder for underlying causes of Autoimmune Cytopenias?
  • 2019 Session | Oncofertility Programs: More Than Just Sperm Banking
  • 2019 Session | The (Financial) Cost of a "Cure"
  • 2019 Session | (2001) Potential Utility of MRD to Identify Relapse in pALL Patients Treated with Tisagenlecleucel
  • 2019 Session | (2002) Lentiglobin Gene Therapy in Transfusion-Dependent Β-Thalassemia Patients with Non-β0/β0 Genotypes
  • 2019 Session | (2003) Mechanisms of Resistance to the Type II JAK2 Inhibitor CHZ868 in B-Cell Acute Lymphoblastic Leukemia
  • 2019 Session | (2004) Discovering Noncoding Genetic Elements that Regulate Globin Synthesis
  • 2019 Session | (2005) Emapalumab in Pediatric Patients with Primary Hemophagocytic Lymphohistiocytosis: Safety & Efficacy
  • 2019 Session | (2006) Modeling IKZF1 Lesions in B-cell Acute Lymphoblastic Leukemia Reveals Potential Therapeutic Targets
  • 2019 Session | (2007) Prognostic Determinants in Childhood T-cell Acute Lymphoblastic leukemia: Results of DFCI 05001
  • 2019 Session | (2008) Gap Junction Interference increases Apoptosis in ALL cells and augments effects of Antimetabolites
  • 2019 Session | (2009) Hydroxyurea Lowers Tricuspid Regurgitant Jet Velocity in Children with Sickle Cell Anemia
  • 2019 Session | (2010) Novel Next-Generation Sequence based Assay for Non-Invasive Prenatal Testing of Sickle Cell Disease
  • 2019 Session | (2011) Gabapentin for Pain in Sickle Cell Disease: Results of a Randomized Phase II Clinical Trial
  • 2019 Session | (2012) Quality of Life is the most important Indication for Second-Line ITP Treatment in Children
  • 2019 Session | (2013) BCL2-Inhibitor Response in Neuroblastoma: Biomarkers and Therapy Resistance
  • 2019 Session | (2014) The Clinical Application of Molecular Testing in Pediatric Solid Tumors: An Institutional Experience
  • 2019 Session | (2015) Enhancing Tumor Directed T Cells with an Interleukin-7 Signal Modulator
  • 2019 Session | (2016) Epigenome Screening Identifies Transcriptional Elongation as Therapeutic Vulnerability in DIPG
  • 2019 Session | (2017) Levofloxacin Prophylaxis
  • 2019 Session | (2018) Renal Tumors: Future Roadmap
  • 2019 Session | (2019) Soft Tissue Sarcoma
  • 2019 Session | (2020) Realizing Effectiveness across Continents with Hydroxyurea (REACH): A Prospective Multi-National Trial of Hydroxyurea for Sickle Cell Anemia in Sub-Saharan Africa
  • 2019 Session | (2021) Leucine for the Treatment of Transfusion Dependence in Patients with Diamond Blackfan Anemia
  • 2019 Session | (2022) A Phase 1/2 Trial of Investigational Spk-8011 in Hemophilia a Demonstrates Durable Expression and Prevention of Bleeds
  • 2019 Session | (2023) Peripherally Inserted Central Catheters (PICCs), the Leading Cause of Central Venous Catheter Associated Thrombosis in Children
  • 2019 Session | The Role of Survivorship Research in Advancing Childhood Cancer Care and Quality of Survival
  • 2019 Session | (2024) Septic Shock (SS) Incidence in National ALL & AML Cohorts using Administrative & Clinical Trial Data
  • 2019 Session | (2025) Nelarabine Abrogates Relapse Rates in CNS-3 T-ALL: A Report from Children’s Oncology Group AALL0434
  • 2019 Session | (2026) Current Cancer Survivorship Practices: A Report from the Children’s Oncology Group (COG)
  • 2019 Session | (2027) Intra-Arterial Chemotherapy for Retinoblastoma: A 7-year Single Institution Experience
  • 2019 Session | Advancing Discovery in Hematology: Bench to Bedside? No. Bedside to Bench to Bedside...
  • 2019 Session | (2028) The Shwachman Diamond Syndrome Registry: Hematologic Complications
  • 2019 Session | (2029) Characteristics and Outcomes of Unprovoked Venous Thromboembolism in the Pediatric Population
  • 2019 Session | (2030) Third Party VST are an effective Therapy for the Treatment of BK-Virus Reactivation after Transplant
  • 2019 Session | (2031) Inhibition of Nemo-Like Kinase improves Erythropoiesis in Models of Diamond Blackfan Anemia
  • 2019 Annual Meeting Session Recordings
  • CI SIG Webinar

eNews

April 2021

Table of Contents

  • President's Message
  • Upcoming Programming
    • ASPHO Summer Symposium
    • Coming Soon: ASPHO Clinical Video Series
  • Conference Central
    • Join Us for the 2021 ASPHO Conference
    • 3 Weeks Left to Register for #ASPHO2021
    • Raffle Winners!
    • Coffee Chats, Yoga, Art Therapy, Roundtables—and More Ways to Engage—at #ASPHO2021
    • Young Investigator, Early Career, and Advanced Practice Professional Award Announcements
    • Accepted Papers and Posters
    • Thank You to Our 2021 Conference Sponsors
    • Take a Look at the #ASPHO2021 Satellite Symposia and Education Theaters
  • Society News
    • Career Path Spotlight Series
    • Now Available: KARE: Knowledge and Assessment REsources (KARE) Toolkit, 2021 Edition
  • Membership Bulletin
    • Diversity Corner
    • Thank You to Our Volunteers!
  • Case Quiz
  • Industry Relations Council
  • Career Center

President's Message

Jorge Di Paola

Presidential Symposium to Address Racial and Socioeconomic Disparities in Care

Jorge Di Paola, MD

Dear Colleagues,

The COVID-19 pandemic has unveiled and exacerbated the profound existing disparities in socioeconomic conditions across racial lines in the United States, with COVID-19 disproportionally affecting Black, Hispanic, Asian, and Native American communities. As Dr. Martin Luther King, Jr., declared at the Convention of the Medical Committee for Human Rights in Chicago in 1966, “Of all forms of inequality, injustice in health is the most shocking and inhuman.” Many of our patients in pediatric hematology/oncology have long suffered the impact of these inequalities, affecting their care and outcomes. Therefore, during this year’s ASPHO Conference, we will attempt to address some of these issues in the Presidential Symposium scheduled for the morning of Thursday, April 22.

For that purpose, we have two distinguished speakers and leaders in the field from our own subspecialty ranks joining us to discuss the impact of racial and socioeconomic disparities in pediatric hematology/oncology. Dr. Allison King, MD PhD MPH, is a professor of pediatrics, medicine, occupational therapy, surgery (Division of Public Health Science), and education at Washington University in Saint Louis. She will discuss the impact of healthcare disparities in hematology, with a particular emphasis on patients with sickle cell disease.

Dr. Smita Bhatia, MD MPH, is a professor of pediatrics and the director of the Institute for Cancer Outcomes and Survivorship in the University of Alabama at Birmingham (UAB) School of Medicine. She also is the vice chair for outcomes in the Department of Pediatrics and associate director of cancer outcomes research at the UAB Comprehensive Cancer Center and a previous recipient of ASPHO’s Frank A. Oski Memorial Lectureship Award. She will discuss disparities in cancer outcomes among children, including a focus on understanding the causes of disparity in these outcomes. Both speakers will present the results of their extensive scientific research efforts to overcome these disparities.

I truly hope you can join us for this timely and exciting program.

Sincerely,
Jorge

Upcoming Programming

ASPHO Summer Symposium

Celebrate and learn from prestigious awardees, lectureship recipients, and presenters at the ASPHO Summer Symposium on Tuesday, July 27, 9:30 am–3 pm CDT!

This special virtual event on Tuesday, July 27, 9:30am – 3:00pm CT will feature research and presentations by individuals recognized for significant contributions to pediatric hematology/oncology. Free to 2021 ASPHO Conference registrants, the event program will celebrate these distinguished award winners and their contributions impacting the science and practice of pediatric hematology/oncology:

  • Recognizing Melissa Hudson, MD, and M. Monica Gramatges, MD,  Northwestern Mutual Award for Excellence in Childhood Cancer Survivorship recipients
  • Bone Marrow Failure and MDS: Lessons from Rare Diseases, Akiko Shimamura, MD PhD, Frank A. Oski Memorial Award and Lectureship recipient
  • Presentations by Alex Kentsis, MD PhD, and Kimberly Stegmaier, MD, St. Baldrick’s Foundation Robert J. Arceci Innovation Award recipients
  • Recognizing Garrett Brodeur, MD, Distinguished Career Award recipient
  • Artificial Intelligence Symposium, Patrick Leavey, MD, Ovidiu Daescu, PhD, and Anthony Chang, MD MBA MPH MS
  • Presentation by Donald Mahoney, MD, George R. Buchanan Award and Lectureship recipient

Up to 4 AMA PRA Category 1 Credits™ available.

Coming Soon: ASPHO Clinical Video Series

Stay tuned for a new way to learn!

Coming soon! After the ASPHO Conference, keep an eye out for ASPHO’s upcoming Clinical Video Series—a four-part hematology video series focusing on anticoagulants and a four-part oncology series focusing on immunotherapy. Each episode is approximately 15 minutes long and will present clinical and scientific education on standards of care, difficult or unique cases, emerging technologies, new research, and innovative therapies. The series aims to provide bite-sized content on demand, when and where you need it. Individual episodes will be available as well as discounted access for the full bundle. More information will be available in May.

Conference Central

ASPHO21 conference

Join Us for the 2021 ASPHO Conference

Listen to Conference Planning Committee Chair Valerie Brown, MD PhD, as she shares highlights of this year’s conference!


3 Weeks Left to Register for #ASPHO2021

Benefit from live and on-demand education and a mix of events perfect for learning, networking, and socializing at this year’s virtual conference.

Register now to connect with colleagues, experts, and thought leaders and gain access to all live programming and on-demand content for up to 90 days following the conference! This year’s virtual event includes opportunities for attendees to learn the latest science, connect with attendees through unique engagement opportunities, and network with colleagues from across the globe. Earn up to 37 AMA PRA Category 1 Credits™ and 10 MOC Part 2 credits. Don’t miss luminary speakers Alexis Thompson, MD MPH, and E. Anders Kolb, MD; 25 Genius Bars; the popular Early Career Roundtable program; and oral presentations and over 350 posters.

Continue your learning with the on-demand conference education available through July 23 and earn CME for every conference education session! Attendees also receive complimentary registration to the ASPHO Summer Symposium on Tuesday, July 27, featuring award and lectureship recipients and presentations by distinguished specialists.

Learn more about the 2021 ASPHO Conference, read the full schedule of events, expert faculty, topics and continuing education information, and bookmark aspho.org/2021-conference for the latest updates on #ASPHO2021!

 

Raffle Winners!

Congratulations to the winners of the free conference registration drawing!

Congratulations to Linda McAllister-Lucas and Katharine Pearsall, winners of the free registration drawing to the 2021 ASPHO Conference! We are happy to offer them complimentary attendance to the ASPHO Conference programs on April 21-23.

Coffee Chats, Yoga, Art Therapy, Roundtables—and More Ways to Engage—at #ASPHO2021

Socialize, network, and share insights at special events connecting you with the global community of pediatric hematology/oncology specialists.

Set aside time to connect, network, and relax at the fun mix of small-group, one-to-one, and group engagement events throughout the conference:

  • Kick off each morning of the conference connecting at the daily Coffee Chat drop-ins, with special tables for first-time attendees and fellows wanting to connect with peers.
  • Participate in pre-selected topic-based roundtable discussions – and create your own themed discussion table!
  • Gain insight and share advice on select diversity topics at the Diversity Dialogue drop-in.
  • Press pause and relax with ASPHO’s prerecorded yoga and meditation sessions.
  • Join your attendees for a chance at prizes at:
    • Art Therapy—attendees will be guided through art therapy techniques to help decompress and destress
    • Magic Show—bring your family and the popcorn as an award-winning magician presents an hour of magic and laughs
    • Networking Reception & Trivia—grab a beverage and flex your smarts as you compete against fellow attendees on your knowledge of pop culture, food and drinks, and all things PHO!

All engagement opportunities are included with registration for the 2021 ASPHO Conference. Be sure to register today to lock in access to these invaluable networking activities and professional connections!

Young Investigator, Early Career, and Advanced Practice Professional Award Announcements

Congratulations to the 2021 Award Recipients!

2021 ASPHO Young Investigator Award Recipients

Jessica Foster, MD
Children’s Hospital of Philadelphia
Philadelphia, PA
Use of mRNA CAR T-Cells for Malignant Pediatric Brain Tumors
jessica foster

Bryan Sisk, MD MSCI
Washington University School of Medicine
St. Louis, MO
Communication Breakdowns in Pediatric Oncology: Contributors, Consequences, and Responses
bryan sisk

2021 Early Career Recipients

Holly Edington, MD
Children's Healthcare of Atlanta/Emory University
Atlanta, GA
Predictors and Outcomes of Immunoglobulin Supplementation in B-Cell Acute Lymphoblastic Leukemia
holly edington

Nura El-Haj, MD
UCSF Benioff Children’s Hospital Oakland
Oakland, CA
Chemotherapy-Induced Sensory Peripheral Neuropathy: The Role of Phosphoinositide 3-Kinase Signaling
nura el-haj

Diana Fridlyand, MD
Children’s Healthcare of Atlanta/Emory University
Atlanta, GA
HSCT Rescues Marrow Failure in A Patient with Leukemia and Previously Undiagnosed Ligase IV Syndrome
MEK Inhibition Overcomes Stromal Cell-Mediated Resistance to MRX-2843, a Dual MERTK/FLT3 Inhibitor
diana fridlyand

Sumit Gupta, MD
University of Texas MD Anderson Cancer Center
Houston, TX
Viroimmunotherapy for Diffuse Intrinsic Pontine Gliomas
sumit gupta

Peter Schoettler, MD
University of Texas Southwestern Medical Center
Dallas, TX
High-Throughput Small Molecule Screening to Identify New Treatments for Pleuropulmonary Blastoma
peter schoettler

2021 Advanced Practice Professional Recipient

Erin Harper, MS, APRN, CPNP-P
St. Jude Children’s Research Hospital
Memphis, TN
Improving Weekend Clinic Handoff, a Single Institution Quality Improvement Effort
erin harper

Accepted Papers and Posters

View the accepted papers and posters here. You can also find them through our Searchable Abstract Database.

Thank You to Our 2021 Conference Sponsors

ASPHO sincerely thanks the sponsors of the 2021 ASPHO Conference. The support our partners provide positively impacts the work of PHO professionals and benefits our joint mission to improve the care of children, adolescents and young adults.

Sponsors

Platinum Level

 NEW JazzPharmaceuticals

Jazz Pharmaceuticals plc (Nasdaq: JAZZ), a global biopharmaceutical company, is dedicated to developing life-changing medicines for people with limited or no options, so they can live their lives more fully and redefine what is possible. As a leader in sleep medicine and with a growing hematology/oncology portfolio, Jazz has a diverse portfolio of products and product candidates in development, and is focused on transforming biopharmaceutical discoveries into novel medicines.

NEW Sobi

As the North American affiliate of international biopharmaceutical company Sobi™, our team is committed to Sobi’s vision of providing sustainable access to innovative therapies and transforming the lives of people affected by rare diseases. We bring something rare to rare diseases – a belief in the strength of focus, the power of agility and the potential of the people we are dedicated to serving. Our product portfolio includes multiple approved treatments, focused on immunology and genetics/metabolism. With North American headquarters in the Boston area, Canadian headquarters in the Toronto area, and field sales, medical and market access representatives spanning North America, our growing team has a proven track record of commercial excellence. More information is available at www.sobi-northamerica.com. For more information about Sobi, visit www.sobi.com.

 

FINAL TBCT logo CMYK 200213 horizontal


Diamond Level

NEW ChildrensHealthcareAtlanta

The Aflac Cancer and Blood Disorders Center is a national leader in pediatric cancer, hematology, and BMT programs. Recognized as one of the top centers in the country by U.S. News & World Report, Children’s cares for 475+ newly diagnosed cancer patients and treats 2,000+ unique sickle cell disease patients annually.

NEW Texas Childrens

Texas Children’s Cancer and Hematology Centers provide individualized, state-of-the-art treatment for children with all forms of cancer and blood disorders. As one of the largest centers in the country, we treat children and adolescents from 50 states and 56 countries and aim to provide the most family-centered, advanced care possible.


Gold Level

NEW Amgen

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. Amgen is one of the world's leading independent biotechnology companies reaching millions of patients and is developing a pipeline of medicines with breakaway potential.

For more information, visit www.amgen.com and follow us on www.twitter.com/amgenoncology.

NEW Childrens Health

Children’s Health is the eighth-largest pediatric health care provider in the nation and the only pediatric cancer program affiliated with the UT Southwestern Harold C. Simmons Comprehensive Cancer Center, the only NCI-designated comprehensive cancer center in North Texas. We are also one of only five comprehensive bleeding disorders and thrombosis programs in Texas offering patients access to the latest clinical trials and therapies unavailable at other facilities.

NEW GBT

Global Blood Therapeutics (GBT) is a biopharmaceutical company dedicated to the discovery, development and delivery of life-changing treatments that provide hope to underserved patient communities. Founded in 2011, GBT is delivering on its goal to transform the treatment and care of sickle cell disease (SCD), a lifelong, devastating inherited blood disorder. The company has introduced Oxbryta™ (voxelotor), the first FDA-approved treatment that directly inhibits sickle hemoglobin polymerization, the root cause of SCD. GBT is also advancing its pipeline program in SCD with inclacumab, a p-selectin inhibitor in development to address pain crises associated with the disease. In addition, GBT’s drug discovery teams are working on new targets to develop the next generation of treatments for SCD. To learn more, please visit www.gbt.com and follow the company on Twitter @GBT_news.

NEW Novartis

NEW Sanofi Genzyme

Sanofi Genzyme focuses on developing specialty treatments for debilitating diseases that are often difficult to diagnose and treat, providing hope to patients and their families. Learn more at www.sanofigenzyme.com.

NEW StanfordChildrens

We bring cutting-edge, compassionate care to each patient. Our physician scientists are working on innovative new treatments, including immunotherapy, making stem cell transplantation safer and more accessible with αβ depletion, antibody-based conditioning and Tr1 cells, and gene therapy to treat sickle cell disease, Fanconi anemia and pyruvate kinase deficiency.


Silver Level

NEW BluebirdBio

bluebird bio is pioneering gene therapy with purpose. From our Cambridge, Mass., headquarters, we're developing gene and cell therapies for severe genetic diseases and cancer, with the goal that people facing potentially fatal conditions with limited treatment options can live their lives fully. beyond our labs, we're working to positively disrupt the healthcare system to create access, transparency, and education so that gene therapy can become available to those who can benefit.

Our goal is to recode the science, the system - and even the status quo - for life.

NEW Chiesi

Chiesi Global Rare Diseases (GRD) is a business unit of the Chiesi Group, a global company with 85 years of experience in the pharmaceutical industry and operating in 29 countries. Founded in February 2020 and based in Boston, Massachusetts, Chiesi GRD works in collaboration with Chiesi Group to harness the full resources and capabilities of our global network to bring innovative new treatment options to people living with rare diseases.

Genetech

As the founders of the biotechnology industry, our goal is to use the power of genetic engineering and advanced technologies to make medicines that address unmet medical needs, and help millions of people worldwide.

NEW PierreFabre

In 2014 Pierre Fabre Pharmaceuticals, Inc. received FDA approval for HEMANGEOL™ (propranolol hydrochloride) oral Solution with a new pediatric indication for the treatment of Infantile Hemangioma requiring systemic therapy. To find out more about HEMANGEOL™ and Pierre Fabre Pharmaceuticals, please visit www.hemangeol.com.

Brands: HEMANGEOL™ (propranolol hydrochloride) Oral Solution is a FDA-approved drug indicated for the treatment of proliferating Infantile Hemangioma requiring systemic therapy.

Take a Look at the #ASPHO2021 Satellite Symposia and Education Theaters

Take a look below to see some of our Satellite Symposia and Education Theaters that will be featured at the 2021 ASPHO Conference. We are grateful to our partners for helping in making this year's virtual event a success!

Meeting Therapeutic Challenges in Pediatric ALL: Expert Perspectives on the Use of Asparaginase Compounds

CME Morning Symposium (Hematology topic)

Speaker:

Rachel E. Rau, MD; Baylor College of Medicine, Dallas, Texas

Please join our discussion on:

  • The modern shape of pediatric ALL care and the role of asparaginase compounds
  • The clinical implications of Escherichia coli asparaginase hypersensitivity and asparaginase discontinuation in pediatric acute lymphoblastic leukemia (ALL)
  • Developing protocols for the management of E coli asparaginase hypersensitivity, including appropriate monitoring and the integration of novel Erwinia asparaginase options

This CME symposium is supported by an educational grant from Jazz Pharmaceuticals, Inc.

Gene Therapy: New Horizons for β-Hemoglobinopathies

Non-CME Afternoon Symposium 

Speakers: 

Matthew Heeney, MD; Melissa Bonner, PhD; Christine Duncan, MD

Please join our discussion on:

  • Unmet needs and challenges in β-hemoglobinopathies
  • Fundamentals of gene therapy: changing the blueprint
  • Gene therapy in β-hemoglobinopathies

This non-CME symposium is supported by bluebird bio.

Aiming Targeted Medical Therapies at Neurofibromatosis Type 1: An Interactive, Case-Based Guide for the Pediatric Hematologist/Oncologist

CME Morning Symposium

Speakers:

AeRang Kim, MD, PhD (Chair); Michael J. Fisher, MD; Andrea M. Gross, MD

Please join our discussion on:

  • Reviewing traditional management modalities for treating NF1-associated plexiform neurofibromas, including surgery, radiation, and surveillance, and emphasize the crucial clinical chasms that remain.
  • Evaluating the pharmacologic rationale and emerging clinical trial data for MEK inhibitors and other novel targeted therapies in NF1-associated tumors (plexiform neurofibromas, low-grade gliomas, and malignant peripheral nerve sheath tumors).
  • Discussing the critical role of the pediatric hematologist/oncologist in delivering targeted medical therapies in NF1, and design evidence-based, multidisciplinary treatment strategies for symptomatic, inoperable NF1-related plexiform neurofibromas.

This CME symposium is presented by Creative Educational Concepts (CEC Oncology) and supported by an independent educational grant from AstraZeneca.

Iron Overload and Alloimmunization in Patients with Sickle Cell Disease: Does the Transfusion Method Make a Difference?

Non-CME Morning Symposium (Hematology topic)

Moderator:

Adeola Davis, PhD, MPA

Speaker:

Deva Sharma, MD, MS, Hematology & Transfusion Medicine, Vanderbilt University Medical Center

Please join our discussion on:

  • Reviewing the pathophysiology of sickle cell disease.
  • What are the differences between the types of transfusion therapy for patients with sickle cell disease (SCD)?
  • What does the current literature say on managing transfusional iron overload and alloimmunization?

This non-CME symposium is supported by Terumo.

Iron Overload in Transfusion-Dependent Patients: Implications for End Organ Damage and COVID-19

Non-CME Afternoon Symposium

Speaker:

Caterina Minniti, MD

This non-CME symposium is supported by Chiesi USA.

Splenomegaly in Children: When It’s Not a Malignancy

Non-CME Afternoon Symposium

Please join our discussion on:

  • The Sanofi Genzyme medical symposium will include a review of the current literature regarding the natural history of Gaucher disease (GD) and acid sphingomyelinase deficiency (ASMD), the diagnostic approaches, as well as describe the underlying metabolic defect and pathophysiology of both diseases.

This non-CME symposium is supported by Sanofi.

Expert Perspective: The First HbS Polymerization Inhibitor to Treat the Root Cause of Sickle Cell DiseaseCME Morning Symposium (Hematology topic)

Speaker:

Ahmar Zaidi, MD

Please join us to learn about the underlying pathophysiology of sickle cell disease. We will discuss inheritance patterns of sickle cell genotypes, the pathology leading to red blood cell sickling, and how this leads to subsequent hemolysis, anemia, and vaso-occlusions. This program will also review the clinical efficacy and safety of the first and only FDA-approved hemoglobin polymerization inhibitor for patients with sickle cell disease.

Non-Invasively Diagnosing Infections in Pediatric Patients with Hematologic Malignancies

Speaker:

Frederick Goldman, MD, Director, Blood and Marrow Transplant Program, Children's of Alabama

In this session, Dr. Goldman shares his experience on how he has used the Karius Test to diagnose infections in pediatric patients with hematologic malignancies.

Gaucher Disease: An Opportunity to Recognize and Diagnose Patients for Pediatric Hematologists

Speaker:

Joel Weinthal, MD, Texas Oncology Pediatrics, Medical City Children’s Hospital

Society News

Career Path Spotlight Series

Read about Dr. Jennifer Andrews’s career path in this issue’s Career Path Spotlight!

The ASPHO Training Committee is excited to present this month’s edition of the Career Path Spotlight series. This resource showcases the career paths of a variety of ASPHO physician members and informs medical students, residents, pediatric hematology/oncology fellows, and early-career junior faculty members of the career opportunities available to them.

This month’s spotlight features Dr. Jennifer Andrews from Vanderbilt University Medical Center in Nashville, TN!

jennifer andrews

Access the April Spotlight.

Now Available: KARE: Knowledge and Assessment REsources (KARE) Toolkit, 2021 Edition

Reinforce your subspecialty knowledge with The KARE Toolkit, updated for 2021!

With the KARE: Knowledge and Assessment RRsources and PHO Review Course On-Demand, specialists at every career stage can use self-assessment tools and on-demand content to review core principles to build and maintain clinical expertise, receive CME or Maintenance of Certification (MOC) Part 2 points, and prepare for anticipated MOC changes.

These online products are convenient as standalone or companion resources and available at a special price when purchased together as KARE Plus. Groups of 5 or more can take advantage of the KARE Plus Institutional Group Discount for special savings.

Membership Bulletin

Diversity Corner

Addressing Inclusion in Pediatric Hematology/Oncology Through Telehealth During the Pandemic

by Nidhi Shah, DO, Chair, Diversity Advisory Group
Telemedicine provides convenient and safe access to health care for vulnerable populations during the pandemic.

The novel Coronavirus has forever changed the landscape of healthcare system in countries around the world, as governments try to limit the spread of a potentially fatal virus through imposition of medically-necessary lockdowns and effective social-distancing measures. The populations most affected by these measures are those that are socioeconomically disadvantaged and those with significant co-morbidities. Low socioeconomic status would likely lead to higher risk of Coronavirus exposure as living conditions are smaller and/or more crowded, with multiple working adults, limited childcare resources, limited access to transportation, and limited financial resources (1). This vulnerable set of patients often overlaps with those that have significant co-morbidities, which could prove fatal in the setting of COVID-19 infection. These co-morbidities, in turn, result in the need for frequent interaction with various healthcare providers, thereby increasing exposure to COVID-19 in a high-risk environment. Efforts to adhere to social distancing measures and, at times, lockdown restrictions have impacted access to healthcare providers. The impact on access is compounded by patient attempts to navigate challenges associated with limiting exposure, facilitation of childcare resources for siblings in single-parent or limited adult households, various hospital visitor restriction policies, and transportation restrictions.

Telemedicine provides an adequate alternative to in-person clinical encounters for patients where complete physical evaluations are not instrumental to ongoing management of care. In particular, it allows for ongoing close monitoring of a vulnerable population by their physicians and other healthcare providers. While this method of clinical evaluation does rely on the use of technology, typically an internet-accessible smartphone is sufficient and, when possible, often the desired method of interacting with the healthcare system by patients (2). Centers for Medicaid & Medicare Services temporarily revised the reimbursement system in 2020, to be continued in 2021, to accommodate ongoing clinical needs with adequate coverage and compensation given the restrictions involved with in-person clinical encounters (3). Most families are now able to access medical services, with adequate compensation for the physicians and associated healthcare providers and insurance coverage for families. Parents are able to commit to follow-up visits without having to worry about arranging childcare for siblings or transportation issues, have greater flexibility in appointment times, and limit their exposure to Coronavirus. While there are challenges associated with any technology, most hospital systems have adopted telemedicine platforms to meet the current needs of their patient population.

In order to assess telemedicine and telehealth usage during the COVID-19 pandemic, and to look at usage opportunities beyond the pandemic, the ASPHO 2020 Telehealth Survey was conducted by the ASPHO Advocacy Committee and ASPHO Practice Committee. The survey found that telehealth decreased a myriad of challenges related to transportation and travel for patients and families. It also increased access to care in underserved areas and underserved communities. The majority of respondents reported that telehealth had a positive impact on their practice and/or quality of life (52.1% positive, 33.2% no impact, 14.7% negative). For patients and their families, the vast majority noted a positive impact on quality of life (77.1% positive, 17.2% no impact, 5.7% negative) (4). ASPHO continues to explore advocacy for enhancing and continuing telehealth post-COVID.

Telemedicine provides pediatric patients affected by significant co-morbidities and/or who are socioeconomically disadvantaged access to ongoing, essential medical care.

References:

  1. Patel, J.A., Nielsen, F.B.H., Badiani, A.A., Assi, S., Unadkat, V.A., Patel, B., Ravindrane, R., & Wardle, H.  Poverty, inequality and COVID-19: the forgotten vulnerable. (2020, June). Public Health, 183, 110–111.
  2. Lau, J., Knudsen, J., Jackson, H., Wallach, A.B., Bouton, M., Natsui, S., Philippou, C., Karim, E., Silvestri, D.M., Avalone, L., Zaurova, M., Schatz, D., Sun, V., & Chokshi, D.A. Staying connected in the COVID-19 pandemic: telehealth at the largest safety-net system in The United States. (2020, August). Health Aff (Millwood), 39(8), 1437–1442. doi: 10.1377/hlthaff.2020.00903.
  3. Centers for Medicare & Medicaid Services. (2021, March 22).>C2C Telehealth Resources. https://www.cms.gov/About-CMS/Agency-Information/OMH/equity-initiatives/c2c/consumer-resources/telehealth-resources
  4. ASPHO 2020 Telehealth Survey.

Thank You to Our Volunteers!

ASPHO thanks our 2020–2021 member volunteers!

National Volunteer Month is upon us, and ASPHO would like to honor and highlight the contributions of our member volunteers. Their dedication and drive allow the Society to fulfill our strategic goals and mission.

A huge thank you to each of our 2020–2021 member volunteers. Whether you served on a standing committee or task force or as a liaison to an external partner, contributed through member publications, or were involved in an ad hoc project, we appreciate your time and dedication!

ASPHO is also excited to welcome incoming committee volunteers as they begin their terms on standing committees. We hope that you find personal fulfillment from being an integral part of your profession and ASPHO’s progress!

ASPHO provides a year-round open application process to be considered for committee openings. Those submitting applications now through this winter will be considered for committee vacancies for the 2022–2023 Society year. For further information on ASPHO committees and to access the application, please visit our committee webpage.

thank you graphic

Case Quiz

case quizA 4-Year-Old with Anemia and Thrombocytopenia

A 4-year-old female was referred to Gastroenterology for short stature, easy bruising, abdominal pain and constipation by her PCP.

Chandni Dargan, MD
Shabnam Arsiwala MD
Nazia Tabassum Iqbal MD
Mukta Sharma MD MPH
Children’s Mercy Hospital
Kansas City, MO

A 4-year-old female was referred to Gastroenterology for short stature, easy bruising, abdominal pain and constipation by her PCP. She was found to have elevated tissue transglutaminase-Immunoglobulin A and was found to be positive for auto antibodies to endomysial IgA. Duodenal biopsy confirmed celiac disease (CD). CBC with differential performed at that visit is as follows:

diagram

Take the Quiz

Industry Relations Council

Thank You to Our Industry Partners

ASPHO would like to extend a big thank you to our industry partners for their support of our goals and mission of promoting the optimal care of children, adolescents and young adults with blood disorders and cancer by advancing research, education, treatment, and professional practice.

Premier Level

NEW Amgen

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. Amgen is one of the world's leading independent biotechnology companies reaching millions of patients and is developing a pipeline of medicines with breakaway potential.

NEW BluebirdBio

bluebird bio is pioneering gene therapy with purpose. From our Cambridge, Mass., headquarters, we're developing gene and cell therapies for severe genetic diseases and cancer, with the goal that people facing potentially fatal conditions with limited treatment options can live their lives fully. beyond our labs, we're working to positively disrupt the healthcare system to create access, transparency, and education so that gene therapy can become available to those who can benefit.

Our goal is to recode the science, the system - and even the status quo - for life.

Executive Level

Jazz_Pharma_Icon_4C.jpg

Jazz Pharmaceuticals plc (Nasdaq: JAZZ), a global biopharmaceutical company, is dedicated to developing life-changing medicines for people with limited or no options, so they can live their lives more fully and redefine what is possible. As a leader in sleep medicine and with a growing hematology/oncology portfolio, Jazz has a diverse portfolio of products and product candidates in development, and is focused on transforming biopharmaceutical discoveries into novel medicines.

Career Center

Visit the Career Center Today

ASPHO’s Career Center offers resources for resume writing, coaching, reference checks and more.

Take advantage of ASPHO's Career Center resources to stay on top of job openings in the field. Skim the Resources section for resume writing, coaching, reference check, search strategy videos, and more. Create a personal account to save job postings and skim FAQs to learn how to best navigate the site! The Career Center is the go-to source where institutions post employment and targeted recruitment opportunities in the field.

  • Products
    • KARE Toolkit: Knowledge and Assessment Resources
    • Recordings
    • Webinars
    • ASPHOcast
    • 2020 Compensation Survey
  • Online Review Course
  • Pediatric Blood & Cancer
    • Access Journal
    • Online Access Instructions
  • ASPHO eNews
    • August 2015 Enews
    • June 2015 Enews
    • April 2015 Enews
    • February 2015 Enews
    • December 2014 Enews
    • October 2014 Enews
    • August 2014 Enews
    • June 2014 Enews
    • April 2014 Enews
    • February 2014 Enews
    • December 2013 Enews
    • October 2013 Enews
    • August 2013 Enews
    • June 2013 Enews
    • April 2013 Enews
    • February 2013 Enews
    • October 2014 Enews
    • October 2015 Enews
    • December 2015 Enews
    • February 2016 Enews
    • April 2016 Enews
    • June 2016 Enews
    • August 2016 Enews
    • October 2016 Enews
    • December 2016 Enews
    • February 2017 Enews
    • April 2017 Enews
    • June 2017 Enews
    • August 2017 Enews
    • October 2017 Enews
    • December 2017 Enews
    • February 2018 Enews
    • April 2018 Enews
    • June 2018 Enews
    • August 2018 eNews
    • October 2018 eNews
    • February 2019 eNews
    • Member Insights: eNews 2018 Highlights
    • April 2019 eNews
    • June 2019 eNews
    • August 2019 eNews
    • October 2019 eNews
    • December 2019 eNews
    • April 2021 eNews
  • Pediatric Blood & Cancer - Call for Applications for Deputy Editor
  • October 2015 Enews
  • Advocacy Sample
  • Health Policy & Advocacy
    • 2016 August Advocacy Brief
    • 2016 December Advocacy Brief
    • 2017 February Advocacy Brief
    • 2017 May Advocacy Brief
    • 2017 September Advocacy Brief
    • 2017 November Advocacy Brief
    • 2018 Advocacy Brief - March
    • Contact Your Members of Congress
    • 2018-Advocacy-Brief-June
    • 2018-Advocacy-Brief-September
    • Advocacy Brief December 2018
    • 2019 Advocacy Brief - March
    • March 2019 Advocacy Brief
    • June 2019 Advocacy Brief
    • September 2019 Advocacy Brief
    • March 2020 Advocacy Brief
    • June 2020 Advocacy Brief
    • September 2020 Advocacy Brief
    • December 2020 Advocacy Brief
  • 2017 Workforce Survey Report
  • Help Fund the STAT Act
  • Practice and Quality
    • Choosing Wisely®
    • Endorsements
    • ASPHO Endorsements member only
  • COVID–19 Resources
Advertising, Exhibits, & Support | Career Center | Calendar | Contact Us
Terms of Use & Privacy Policy » © The American Society of Pediatric Hematology/Oncology